Position in NVO
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$24,205,768
+$12,175,399 QoQ
Shares Held
504,918
+54.2% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
5.00%
of 13F equity value
Holder Rank
#88
of 1,348 holders
Holding Since
Jun 2024
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Simplify Asset Management Inc. holds $101,858,817 across 8 Drug Manufacturers - General names. NVO ranks #1 (23.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
This page
|
504,918 | $24,205,768 | |
| 2 | JNJ |
Johnson & Johnson
|
72,879 | $18,509,079 | |
| 3 | LLY |
ELI LILLY & Co
|
14,715 | $17,649,613 | |
| 4 | ABBV |
AbbVie Inc.
|
64,461 | $16,220,966 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
81,325 | $10,274,600 | |
| 6 | AMGN |
Amgen Inc
|
20,974 | $7,595,104 | |
| 7 | AZN |
Astrazeneca PLC
|
34,188 | $6,482,728 | |
| 8 | MRK |
Merck & Co., Inc.
|
7,167 | $920,959 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,205,768 | 504,918 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $12,030,369 | 327,357 | Shares | Sole | 2026-04-27 | |
| 2024-06-30 | $5,627,809 | 39,427 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||